Published in Pediatr Infect Dis J on March 01, 1996
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol (1997) 2.53
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother (2001) 2.13
Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol (2006) 1.71
Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev (2002) 1.59
Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol (2010) 1.43
Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis (2008) 1.40
Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol (2005) 1.38
Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol (2004) 1.28
Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. J Clin Microbiol (1999) 1.27
Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol (2002) 1.22
Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother (2004) 1.21
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica (Cairo) (2013) 1.14
Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses. J Clin Microbiol (1998) 1.13
Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 1.07
Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients. J Pediatric Infect Dis Soc (2012) 0.99
Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity. Clin Vaccine Immunol (2007) 0.98
Mannosylation in Candida albicans: role in cell wall function and immune recognition. Mol Microbiol (2013) 0.97
Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol (2005) 0.97
Aspergillus antigen testing in bone marrow transplant recipients. J Clin Pathol (2000) 0.88
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing. Clin Infect Dis (2015) 0.88
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol (2000) 0.87
The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children. Curr Fungal Infect Rep (2013) 0.87
Detection of Aspergillus galactomannan: comparison of an enzyme-linked immunoassay and a europium-linked time-resolved fluoroimmunoassay. J Clin Microbiol (1998) 0.80
A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus. J Clin Pathol (1999) 0.78
Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis. BMC Infect Dis (2015) 0.75
Serum galactomannan levels in the diagnosis of invasive aspergillosis. Korean J Intern Med (2015) 0.75
Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol (2000) 18.21
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. N Engl J Med (1998) 4.95
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol (1989) 4.17
Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science (1997) 3.67
A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol (1995) 3.60
Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun (1992) 3.23
CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother (2001) 3.07
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain (2005) 2.89
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology (2001) 2.65
Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun (1994) 2.60
Celiac disease and Turner syndrome. J Pediatr Gastroenterol Nutr (1998) 2.33
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother (1991) 2.31
Escherichia coli native valve endocarditis. Clin Microbiol Infect (2006) 2.28
Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr (1989) 2.22
Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect Immun (2000) 2.19
Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res Microbiol (1996) 2.11
Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus. Infect Immun (1997) 1.94
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89
Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis (1996) 1.89
Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant (1998) 1.87
Molecular epidemiology of nosocomial invasive aspergillosis. J Clin Microbiol (1994) 1.87
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet (2008) 1.83
Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol (1998) 1.83
Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol (1990) 1.83
Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett (1993) 1.80
Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet (1993) 1.72
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol (1998) 1.68
Molecular diagnosis and epidemiology of fungal infections. Med Mycol (1998) 1.64
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Afut1, a retrotransposon-like element from Aspergillus fumigatus. Nucleic Acids Res (1996) 1.64
Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates. J Clin Microbiol (2001) 1.64
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect Immun (1996) 1.60
In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy. J Antimicrob Chemother (2001) 1.57
A comprehensive linkage map of the pig based on a wild pig-Large White intercross. Anim Genet (1996) 1.54
Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer (2002) 1.53
Nonspecific factors involved in attachment of entomopathogenic deuteromycetes to host insect cuticle. Appl Environ Microbiol (1988) 1.52
Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography; correlation with echocardiography and surgery. Int J Cardiovasc Imaging (2005) 1.51
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48
Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol (2010) 1.47
Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr (1999) 1.44
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev (2004) 1.43
Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease. Eur Heart J (1999) 1.42
Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob Agents Chemother (2001) 1.38
Efficiency of prenatal counselling for sickle cell disease in Guadeloupe. Genet Couns (1997) 1.38
Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France. J Infect Dis (1996) 1.35
Yeast Ty1 retrotransposition is stimulated by a synergistic interaction between mutations in chromatin assembly factor I and histone regulatory proteins. Mol Cell Biol (1998) 1.34
Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet (1997) 1.34
Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiol Infect (1991) 1.33
Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother (2001) 1.32
Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011. Euro Surveill (2011) 1.31
The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood (1996) 1.30
Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients. J Infect Dis (1994) 1.30
Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob Agents Chemother (1999) 1.29
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet (2010) 1.27
The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem (1999) 1.27
Jumper's knee. Am J Sports Med (1983) 1.26
Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study. Occup Environ Med (2004) 1.25
Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children. Br J Haematol (2001) 1.24
Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant. Clin Infect Dis (1992) 1.24
Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J Clin Microbiol (1996) 1.23
Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22
Wood degradation by white rot fungi: cytochemical studies using lignin peroxidase-immunoglobulin-gold complexes. Appl Environ Microbiol (1987) 1.21
Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis. Res Microbiol (1994) 1.20
Restricted diversity of V gamma 9-JP rearrangements in unstimulated human gamma/delta T lymphocytes. Eur J Immunol (1992) 1.19
Prevalence and clinical picture of celiac disease in italian down syndrome patients: a multicenter study. J Pediatr Gastroenterol Nutr (2001) 1.19
Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant (2005) 1.17
Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. J Clin Microbiol (1998) 1.16
The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli. FEMS Microbiol Lett (2001) 1.16
Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant (2001) 1.14
Possible person-to-person transmission of Escherichia coli O111--associated hemolytic uremic syndrome. Pediatr Nephrol (1997) 1.14
Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet (1999) 1.13
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect (2007) 1.13
Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43. Am J Hum Genet (1996) 1.12
Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital. J Clin Microbiol (1992) 1.12
Mobilization of Ca2+ by cyclic ADP-ribose from the endoplasmic reticulum of cauliflower florets. Plant Physiol (2001) 1.11
Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood (1995) 1.11
Clinical significance of cytomegalovirus viremia in bone marrow transplantation. Transplantation (1985) 1.11
Treatment of Leaks Following Sleeve Gastrectomy by Endoscopic Internal Drainage (EID). Obes Surg (2015) 1.11
Calreticulin, a multifunctional Ca2+ binding chaperone of the endoplasmic reticulum. Biochem Cell Biol (1998) 1.10
Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS (2000) 1.09
Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia (2000) 1.08
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol (2001) 1.08
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol (1991) 1.08
Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France. J Infect Dis (2000) 1.08
Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid antigen detection test for group A streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis (2013) 1.07
Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med (1990) 1.07